The recent transfer of João Félix from Chelsea to AC Milan marks a significant shift for the Portuguese forward, who has struggled to find consistent playing time in London. After Chelsea acquired him for over £50 million, Félix started only three Premier League matches this season under coach Enzo Maresca.
Eager for a more prominent role, he has sought opportunities elsewhere, with AC Milan stepping in as a viable option.
Milan’s interest in Félix stems from their need for greater creativity and depth in their attack. The club’s new manager, Sérgio Conceição, is particularly excited about the prospect of bringing Félix into the fold, recognizing his potential to enhance their offensive capabilities.
Negotiations have progressed, with Milan reportedly agreeing to cover Félix’s salary and pay a loan fee exceeding £5 million for the rest of the season.
⚫️ João Félix to AC Milan, here we go! Official bid accepted by Chelsea for straight loan with no buy option.
Salary covered by AC Milan and package in excess of £5m with loan fee.
João now set for AC Milan medical after his green light to the move last night. pic.twitter.com/3xb0LO5XHP
— Fabrizio Romano (@FabrizioRomano) February 3, 2025
While Chelsea was initially reluctant to let Félix go, the club now appears ready to facilitate the transfer given the current situation.
The agreement does not include a purchase option, reflecting Chelsea’s desire to retain control over his future while allowing him to gain valuable playing time in Serie A.
As the transfer window approaches its end, both clubs are eager to finalize the deal.
Félix is set to undergo a medical examination with AC Milan, signaling that he is on the brink of revitalizing his career in Italy.
This transfer could be pivotal not only for his personal aspirations but also for Milan’s goals as they aim to strengthen their squad.
The excitement surrounding this transfer highlights the dynamic nature of football and the ongoing evolution of player situations.
Don’t Miss | Kendrick Lamar’s “Not Like Us” Wins Big at 2025 Grammy Awards
